Nitrosamines are a concern to the FDA because if their known carcinogenic risk
We also recommend a few other lifestyle changes you can make, in addition to Semaglutide, to help you get the best outcome possible
The nausea, vomiting, and diarrhea commonly associated with semaglutide therapy can lead to reduced fluid intake or increased fluid loss, potentially resulting in dry mouth (xerostomia)
When Wegovy is introduced, its gastrointestinal effects may overlap with existing post-cholecystectomy symptoms, potentially making digestive side effects more noticeable or troublesome
Multiple Endocrine Neoplasia syndrome type 2 (MEN2): This genetic condition increases risk of MTC
Dose escalation is guided by your provider based on your response and tolerability